HIV and TB activist Winstone Zulu has Died

The prominent HIV and TB activist Winstone Zulu has died at the age of 47 in hospital in Lusaka.

Mr Zulu was diagnosed with HIV in 1990 and was the first person in Zambia to make a public statement about his HIV status.

He began to take antiretroviral treatment in 1996 and contracted tuberculosis in 1997. After effective treatment for TB he became one of the first HIV activists to champion the need to address TB. One of 13 children, Winstone Zulu lost four brothers and two sisters-in-law to TB between 1990 and 2003.

Not only was Winstone Zulu a hero in the fight against AIDS, but he was also a pioneer in bringing AIDS activism to the hitherto barren and civil society free zone of tuberculosis prevention, treatment, and care,” said Mark Harrington, executive director of Treatment Action Group.

“Winstone was lovely, a courageous, insightful, gentle and eloquent activist and a real pioneer of the HIV and TB access movements for Africans in Africa. He was also that rare thing, a heterosexual man who was honest, wise and funny about male sexuality. He didn’t just defy three epidemic diseases (he had polio as well as HIV and TB), he also survived AIDS denialism,” said Gus Cairns of NAM.

Winstone Zulu stopped HIV medication in 2000 after encountering AIDS denialist views that HIV did not cause AIDS.  He resumed treatment in 2002 after a huge decline in his CD4 cell count left him once again seriously ill.

He continued to play a prominent role in AIDS and TB activism and was praised by Nelson Mandela as a pioneer of TB activism at the 2004 World AIDS Conference. In 2006 he was awarded the Stop TB Partnership Kochon prize for his contribution to TB control.

Speaking at numerous international conferences and events, Winstone sounds the alarm on the links between HIV/AIDS and TB and advocates for increased financial resources and improved programs to combat TB and TB-HIV. During recent trips to Japan, Winstone has garnered over a dozen media hits, including several front page articles in major outlets, particularly around his meetings with the then Prime Minister of Japan and the current Deputy Prime Minister.

Winstone’s experiences and actions make him a leader in TB advocacy and speak volumes to the social attention and political will that can be generated by just one individual using his voice.

In the following video, Winstone addresses the TED conference on 8th October 2008.

“Winstone Zulu worked tirelessly to change the world, at no small cost to his own health and wellbeing,” said Mark Harrington. “His legacy is a stronger link between HIV and TB activists, but his inimitable calm and passionate voice of reason will be deeply missed.

Winstone Zulu is survived by his wife Vivian and their four children.

Original Articles via NAM and Action.org

STAY UPDATED

or subscribe via email

Information about the effort and influence surrounding HIV/AIDS prominent activists is available here.

Related articles

• AIDS Treatment is Good Value for Money, Says New Study (lass.org.uk)
• Door-To-Door Compulsory HIV Testing on the Table (lass.org.uk)
• Mobile Testing Units Show Success in Linking People to HIV Care (lass.org.uk)
• Malaria, TB and HIV/AIDS (lynhallewell.wordpress.com)
• September Round Up (lass.org.uk)

HIV Could Spread If Birth Control Injections Increase, Warn Scientists

Researchers call for new guidelines for women using family planning services in Aids-hit areas.  Campaigns to increase the number of women opting for long-lasting contraceptive injections in Aids-hit parts of the developing world could be helping to spread the epidemic, scientists are warning.

New research shows that women who use hormonal contraceptives may double their risk of contracting HIV and of passing it to their male partner, throwing up a new dilemma for global development.

The authors of the large-scale study, published in the journal Lancet Infectious Diseases, call for urgent guidance to be drawn up and given to women using family planning services in HIV-endemic areas. The study showed particularly that the risk of HIV transmission was raised by the long-lasting injections that are most widely used and most popular in the sub-Saharan regions worst hit by the Aids epidemic.

The results present a significant problem for global health and development. Unwanted pregnancy is a threat to a woman’s life and can lead to greater poverty and deprivation for her family. The more children she has, the harder it will be to feed and educate them.

While family planning is still resisted in parts of the developing world, campaigns to promote injectable contraception have met with some success. Many women have sought out the injections that last for months and that they can sometimes get without their husband’s knowledge if he refuses permission.

But the study of 3,800 couples shows that there is a risk which has previously been suspected but unconfirmed. The risk was present for those who took the pill too, but it was not statistically significant because most women in the study had opted for injections.

“These findings have important implications for family planning and HIV-1 prevention programmes, especially in settings with high HIV-1 prevalence”, said Jared Baeten from the University of Washington, Seattle, one of the study’s authors.

“Recommendations regarding contraceptive use, particularly emphasising the importance of dual protection with condoms and the use of non-hormonal and low-dose hormonal methods for women with or at risk for HIV-1, are urgently needed,” said lead study author Renee Heffron, also from the University of Washington.

More than 140 million women worldwide use some form of hormonal contraception.

The study group comprised 3,790 couples where one partner had HIV (usually the woman) although the other did not. They were drawn from two existing studies of HIV incidence in seven African countries – Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda and Zimbabwe.

The researchers found that women who did not have HIV were twice as likely to be infected by their partner if they were using hormonal contraception. Those who had HIV themselves were twice as likely to give it to their partner. Tests showed that women with HIV using injectable contraception had raised concentrations of virus inside the cervix. Researchers are unclear why and a larger study specifically designed to look at this issue should be carried out, they say.

Meanwhile women should be told there may be an increased risk of HIV infection if they use hormonal contraception and should be counselled that condoms will give them dual protection.

In a comment published by the journal, Charles Morrison from Clinical Sciences, Durham, USA, said: “Active promotion of DMPA [injectable contraception] in areas with high HIV incidence could be contributing to the HIV epidemic in sub-Saharan Africa, which would be tragic. Conversely, limiting one of the most highly used effective methods of contraception in sub-Saharan Africa would probably contribute to increased maternal mortality and morbidity and more low birth weight babies and orphans—an equally tragic result. The time to provide a more definitive answer to this critical public health question is now; the donor community should support a randomised trial of hormonal contraception and HIV acquisition.”

Original Article by Sarah Boseley, health editor at The Guardian

STAY UPDATED

or subscribe via email

Related articles

• African women spread HIV more when on the pill: study (ctv.ca)
• Study: HIV risks rise with some birth control (cbsnews.com)
• Are You at Risk of Contracting HIV? (lass.org.uk)